Menu
Back to Journals » Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy » Volume 14
Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients
Authors Zhou X, Luo M, Zhou S, Cheng Z, Chen Z, Yu X
Received 2 November 2020
Accepted for publication 22 December 2020
Published 27 January 2021 Volume 2021:14 Pages 379—385
DOI https://doi.org/10.2147/DMSO.S290072
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Juei-Tang Cheng
Xin Zhou,* Mei Luo,* Sha Zhou, Zhiling Cheng, Zhongpei Chen, Xiaoxia Yu
Department of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400000, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Xiaoxia Yu
Department of Endocrinology, Chongqing Traditional Chinese Medicine Hospital, Chongqing 400000, People’s Republic of China
Tel/Fax +86 2363842760
Email yudoctor789@163.com
Objective: To investigate the plasma alarin level in newly diagnosed obese type 2 diabetes mellitus (T2DM) and its correlation with glucose and lipid metabolism and insulin resistance.
Methods: From October 2018 to June 2020, 239 newly diagnosed T2DM patients were collected. According to obesity, patients were divided into T2DM obese group (n=135) and T2DM non-obese group (n =104). Gender, age, body mass index (BMI), blood lipids, blood glucose, glycosylated hemoglobin A1c (HbA1c), fasting insulin (FINS), plasma alarin concentration, homeostasis model assessment for insulin resistance (HOMA-IR), homeostasis model assessment for β-cell function (HOMA-β) and other clinical data were collected and analyzed.
Results: BMI, triacylglycerol (TG), total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-C), fasting blood glucose (FPG), HbA1c, FINS, plasma alarin levels and HOMA-IR in the control group, T2DM non-obese group and T2DM obese group increased sequentially, and high-density lipoprotein-cholesterol (HDL-L) and HOMA-β decreased sequentially (P< 0.05). Correlation analysis results showed that plasma alarin levels in T2DM patients were positively correlated with waistline, BMI, TC, LDL-C, FPG, HbA1c, FINS and HOMA-IR (P< 0.05), and negatively correlated with HDL-C and HOMA-β (P < 0.05), and the correlation coefficient of T2DM obese group was significantly higher than that of T2DM non-obese group (P< 0.05). Multiple linear stepwise regression analysis showed that BMI, FPG, HbA1c, HOMA-β, and HOMA-IR were independent factors related to plasma alarin levels in T2DM non-obese and T2DM obese patients, and the correlation coefficient of the T2DM obese group was significantly higher than that of the T2DM non-obese group (P < 0.05).
Conclusion: Plasma alarin levels increase in newly diagnosed T2DM and obese T2DM patients, which are affected by TC, BMI, FPG, HbA1c, HOMA-β and HOMA-IR, and may be involved in development of T2DM.
Keywords: type 2 diabetes mellitus, obesity, plasma alarin level, insulin resistance, blood sugar, blood lipids, insulin
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.